首页> 外国专利> Quinolone Compounds, Pharmaceutical Composition and use for the treatment of diseases mediated by inhibition of HIF polilhidrolasa, such as myocardial infarction, Stroke, anemia, among others

Quinolone Compounds, Pharmaceutical Composition and use for the treatment of diseases mediated by inhibition of HIF polilhidrolasa, such as myocardial infarction, Stroke, anemia, among others

机译:喹诺酮类化合物,药物组合物以及用于治疗由抑制HIF脊髓灰质炎介导的疾病的方法,例如心肌梗塞,中风,贫血等

摘要

The present invention relates to novel compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
机译:本发明涉及通式(I)的新型化合物,其互变异构形式,其立体异构体,其药学上可接受的盐,包含它们的药物组合物,其制备方法,这些化合物在医学中的用途以及涉及其制备的中间体。

著录项

  • 公开/公告号CL2015001802A1

    专利类型

  • 公开/公告日2015-10-02

    原文格式PDF

  • 申请/专利权人 CADILA HEALTHCARE LIMITED;

    申请/专利号CL20150001802

  • 申请日2015-06-22

  • 分类号C07D215/58;C07D401/04;A61K31/4365;A61K31/437;A61P7/06;

  • 国家 CL

  • 入库时间 2022-08-21 15:15:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号